You just read:

RXi Pharmaceuticals Announces Advancement of its Ophthalmology Franchise with Successful Topical Delivery of sd-rxRNA to the Cornea in an in vivo Corneal Wound Model

News provided by

RXi Pharmaceuticals Corporation

28 Apr, 2016, 07:02 ET